Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles

Author(s):  McPherson Timothy B, Neumann William L, Kolling William M

Issue:  Nov/Dec 2013 - Volume 17, Number 6
View All Articles in Issue

Page(s):  508-511

Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Page 1
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Page 2
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Page 3
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Page 4

Download in electronic PDF format for $75

Abstract:  Tetracaine topical solution may improve patient adherence with topical clotrimazole therapy for fungal otitis externa. The chemical stability of tetracaine 1% and combination clotrimazole 1% with tetracaine 1% topical solutions was determined using a stability-indicating high-performance liquid chromatography assay. Propylene glycol and polyethylene glycol 400 were used as anhydrous solvents. Standard curves for tetracaine and clotrimazole were linear with r2 = 0.999. Clotrimazole did not degrade in either propylene glycol or polyethylene glycol 400 throughout the 90-day study period. Tetracaine degraded significantly in propylene glycol but not in polyethylene glycol 400. A beyond-use date of 90 days is supported for tetracaine and the combination clotrimazole-tetracaine solution in polyethylene glycol 400. A beyond-use date of 60 days is supported for tetracaine and the combination clotrimazole–tetracaine in propylene glycol.

Related Keywords: Timothy B. McPherson, PhD, William L. Neumann, PhD, William M. Kolling, PhD, tetracaine, clotrimazole, topical solutions, topical preparations, patient adherence, fungal otitis externa, stability, propylene glycol, polyethylene glycol 400, PEG 400, topical anesthetic, drug admixtures

Related Categories: EXCIPIENTS, PACKAGING, PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B
, Neumann William L, Kolling William M
Nov/Dec 2013
Pg. 508-511

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Kinetics of Tetracaine Solvolysis in Propylene Glycol
McPherson Timothy B
, Neumann William L, Goolsby Michael, Kolling William M
Jul/Aug 2018
Pg. 329-334

Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
Sep/Oct 2016
Pg. 414

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 73

Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia
, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015
Pg. 261-267

Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 64

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Spennacchio Antonio
, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
May/Jun 2023
Pg. 256-262

Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel
Allen Loyd V Jr
Mar/Apr 1998
Pg. 159

Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles
Dewulf Joseph
, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
May/Jun 2015
Pg. 268-270

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 243

Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan
, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015
Pg. 161-166

Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
Jan/Feb 2016
Pg. 50

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 513

pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L
, Kokki H, Rasi A S, Naaranlahti Toivo J
Nov/Dec 2002
Pg. 471-474

Return to Top